Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer
Clinical trial NCT06759090 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06759090
- Sponsor
- Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2027-01-15
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.